We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$262M
AUM Growth
-$17.6M
Cap. Flow
-$38.9M
Cap. Flow %
-14.82%
Top 10 Hldgs %
58.42%
Holding
182
New
46
Increased
31
Reduced
25
Closed
52

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.95%
2 Healthcare 8.2%
3 Communication Services 2.9%
4 Consumer Discretionary 1.78%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
26
CALL
Invesco QQQ Trust
QQQ
$489B
$1.56M 0.59%
+10,000
New +$1.53M
QQQ icon
27
PUT
Invesco QQQ Trust
QQQ
$489B
$1.56M 0.59%
+10,000
New +$1.53M
COL
28
DELISTED
Rockwell Collins
COL
$1.5M 0.57%
11,100
+6,300
+131% +$844K
MGI
29
DELISTED
MoneyGram International, Inc. New
MGI
$1.5M 0.57%
113,637
-500
-0.4% -$7.29K
AET
30
DELISTED
Aetna Inc
AET
$1.44M 0.55%
8,000
+6,485
+428% +$1.11M
RXDX
31
DELISTED
Ignyta, Inc.
RXDX
$1.44M 0.55%
54,000
+21,000
+64% +$341K
SPA
32
DELISTED
Sparton
SPA
$1.4M 0.53%
60,623
+33,823
+126% +$785K
TVTX icon
33
Travere Therapeutics
TVTX
$6.19B
$1.27M 0.48%
60,336
+19,336
+47% +$442K
OA
34
DELISTED
Orbital ATK, Inc.
OA
$1.24M 0.47%
+9,410
New +$1.25M
UUP icon
35
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$324M
$1.2M 0.46%
50,000
USO icon
36
PUT
United States Oil Fund
USO
$2.03B
$1.2M 0.46%
12,500
-50,000
-80% -$4.44M
EEM icon
37
PUT
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$1.18M 0.45%
+25,000
New +$1.16M
HZNP
38
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.17M 0.45%
80,000
-60,000
-43% -$843K
WGL
39
DELISTED
Wgl Holdings
WGL
$1.06M 0.4%
12,314
+5
+0% +$427
FPRX
40
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$968K 0.37%
44,176
+34,176
+342% +$1.1M
NKE icon
41
CALL
Nike
NKE
$58.7B
$938K 0.36%
15,000
+10,000
+200% +$575K
NKE icon
42
PUT
Nike
NKE
$58.7B
$938K 0.36%
15,000
+10,000
+200% +$575K
RIGL icon
43
Rigel Pharmaceuticals
RIGL
$868M
$931K 0.35%
23,990
+3,990
+20% +$152K
AZN icon
44
CALL
AstraZeneca
AZN
$252B
$868K 0.33%
12,500
-2,500
-17% -$169K
VRAY
45
DELISTED
ViewRay, Inc.
VRAY
$864K 0.33%
93,300
+42,300
+83% +$339K
XOM icon
46
CALL
ExxonMobil
XOM
$644B
$836K 0.32%
10,000
SNI
47
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$768K 0.29%
9,000
+2,500
+38% +$207K
GS icon
48
CALL
Goldman Sachs
GS
$301B
$764K 0.29%
+3,000
New +$736K
GS icon
49
PUT
Goldman Sachs
GS
$301B
$764K 0.29%
+3,000
New +$736K
AFMD
50
DELISTED
Affimed
AFMD
$741K 0.28%
56,977
+25,687
+82% +$487K

Similar funds

Telemetry Investments's Q4 2017 Portfolio in Review

As of Q4 2017, Telemetry Investments held 182 positions worth $262M, down 6.3% from $280M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Telemetry Investments withdrew a net $38.9M in Q4 2017, closing 52 positions and reducing 25 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $3.07M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, up from 76% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Telemetry Investments opened a new position in Buffalo Wild Wings, Inc. worth $2.28M.

  • Telemetry Investments's largest Q4 2017 buy was Buffalo Wild Wings, Inc.: 14,605 shares worth $2.28M.
  • Telemetry Investments added most to Time Warner Inc in Q4 2017, an estimated $2.16M increase.
  • Telemetry Investments's biggest Q4 2017 reduction was Acceleron Pharma, cutting an estimated $604K.
  • Telemetry Investments fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $3.07M.
  • Telemetry Investments's ten largest holdings make up 58% of its $262M portfolio in Q4 2017.
  • Telemetry Investments opened 46 new positions and closed 52 in Q4 2017.
  • Telemetry Investments's portfolio value fell 6.3% quarter-over-quarter to $262M.

Based on Telemetry Investments's 13F filing for Q4 2017, filed 14 Feb 2018.